Riverbend Wealth Management, LLC Bristol Myers Squibb CO Transaction History
Riverbend Wealth Management, LLC
- $143 Billion
- Q3 2025
A detailed history of Riverbend Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Riverbend Wealth Management, LLC holds 8,043 shares of BMY stock, worth $358,235. This represents 0.25% of its overall portfolio holdings.
Number of Shares
8,043
Previous 8,031
0.15%
Holding current value
$358,235
Previous $372 Million
2.42%
% of portfolio
0.25%
Previous 0.28%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...